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The cerebral cortex is responsible for higher functions of the central nervous system (CNS), such as
movement, sensation, and cognition. When the cerebral cortex is severely injured, these functions are
irreversibly impaired. Although recent neurobiological studies reveal that the cortex has the potential for
regeneration, therapies for functional recovery face some technological obstacles. Biomaterials have been
used to evoke regenerative potential and promote regeneration in several tissues, including the CNS. This
review presents a brief overview of new therapeutic strategies for cortical regeneration from the per-
spectives of neurobiology and biomaterial engineering, and discusses a promising technology for evoking
the regenerative potential of the cerebral cortex.
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The cerebral cortex, one of the most highly evolved tissues in
the body, is responsible for higher functions of the central nervous
system (CNS), such as movement, sensation, and cognition. These
higher functions are associated with complex but well-organized
neuronal networks in the cerebral cortex, which is organized into
layers and columns that receive inputs from and send outputs to
the subcortical and other cortical areas. Over a century ago, neu-
roanatomists began investigating and describing the formation ofsting by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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research, believed that the regenerative property of the adult brain
is extremely limited [1], and researchers since have assumed that
the cerebral cortex and other CNS tissues do not regenerate after
injury probably because of the following reasons. 1) Most of the
neurons are generated from neuronal stem/progenitor cells during
developmental stages except for the speciﬁc types of neurons
generated from adult neural stem cells in the adult ven-
tricularesubventricular zone (VeSVZ) of the lateral ventricle and
the dentate gyrus of the hippocampus. 2) Many neural circuits are
shaped during a critical period in early postnatal life and seem to
largely lose plasticity after this period. Indeed, there are no clini-
cally available therapies for regenerating the injured cerebral cor-
tex. However, recent advances in neurobiology reveal that the
cerebral cortex does have regenerative potential, and shed light on
new therapeutic strategies for cortical regeneration. In this review,
I will describe treatment strategies for regenerating the cerebral
cortex after injury from the perspectives of neurobiology and
biomaterial engineering, and identify technical limitations that
these strategies must address.
2. Neurobiological approaches for cortical regeneration
2.1. Neural cell transplantation
During cortical development, cortical excitatory neurons and
inhibitory neurons are generated from neural stem/progenitor
cells in the cerebral cortex and the basal ganglia, respectively [2].
These immature neurons differentiate and form a 6-layered
structure, based mostly on their network patterns. Excitatory
neurons are generated from neural stem/progenitor cells in the
cortical ventricular zone (VZ), which is quite far from the position
where the neurons will eventually align and take their place in the
cortical structure. Newly generated neurons migrate toward the
brain surface, to the region beneath the marginal zone (MZ). Later-
born neurons pass early-born neurons and reach their destination
beneath the MZ ﬁrst, to align at the upper layer. The upper-layer
neurons extend their axons mainly into the intracortical area,
while neurons in deeper layers extend mainly into the subcortical
area. Cortical interneurons also align roughly according to their
order of birth.
Since speciﬁc gene-expression patterns contribute to gener-
ating different types of neurons [3], it is theoretically possible to
manipulate neural stem/progenitor cells in vitro to obtain speciﬁc
types of neurons. Although the developmental process of the ce-
rebral cortex is more complex than that of the retina, the retina
provides a good model for studying the fundamental processes of
CNS development. Photoreceptor cells, a type of retinal neuron, can
be generated from pluripotent stem cells [4,5]. Since the degen-
eration of photoreceptor cells causes vision loss, transplanting
photoreceptor cells into the retina is a promising strategy for
retinal regeneration. Transplanted post-mitotic, immature photo-
receptor cells integrate into the recipient retina more efﬁciently
than do retinal progenitor cells [6]. When normal immature
photoreceptor cells are transplanted into the Gnat1/ mouse
retina, inwhich photoreceptor cells degenerate, vision is recovered
[7]. However, since there are no established techniques for
generating speciﬁc types of cortical neurons, regenerative strate-
gies for the cerebral cortex generally involve transplanting cortical
progenitor cells rather than immature cortical neurons.
When neural stem/progenitor cells are transplanted into the
developing cortex, their progeny neurons align in the correct layer
[8]; this is also the case when progenitor cells are transplanted into
the injured cortex [9]. Although it is not presently possible to
generate speciﬁc types of cortical neurons from pluripotent stemcells, it is possible to generate transplantable neural stem/pro-
genitor cells [10,11]. Transplanted neural stem/progenitor cells
derived from human fetal brain tissue and induced pluripotent
stem (iPS) cells can differentiate into neurons and survive in the
ischemic brain [12,13]. The use of multi-potent mesenchymal stem
cells (MSCs) is another attractive strategy, since MSCs are easily
isolated from bone marrow [14]. Transplanted MSCs can migrate
and differentiate into neurons in the recipient cerebral cortex [15].
Functional recovery has been observed after transplanting em-
bryonic cortical cells [16], neuronal cell line cells [17], neural stem/
progenitor cells derived from iPS cells [18], or MSCs [19] into the
injured cortex. However, it is not certain whether this functional
recovery was caused by new neuronal networks of transplanted
cells themselves or by the trophic factors secreted from trans-
planted cells, which enhances new neuronal networks of existing
neurons in the recipient cortex. Thus, we must identify the factors
that speciﬁcally contribute to functional recovery. For example,
abrogating the transplanted cells after functional recovery will
reveal whether recipient mice require ongoing support from these
cells. Techniques for generating speciﬁc types of cortical neurons
must also be established to obtain more effective transplantable
cells.
2.2. Endogenous adult neural stem cells (NSCs)
The discovery of neural stem cells in the adult VeSVZ of the
lateral ventricle and the dentate gyrus of the hippocampus made it
possible to consider regenerative strategies using endogenous NSCs
[20e23]. In the normal adult, neuroblasts generated at the VeSVZ
migrate into the olfactory bulb (OB), where they differentiate into
mature neurons as part of the olfactory system [24]. When the
cerebral cortex or striatum is injured, these neuroblasts migrate
toward the injured area [25e30]. Therapies using endogenous NSCs
do not require cell transplantation and thus have advantages with
respect to ethical issues and the immune response. However, some
technical issues need to be resolved before endogenous NSCs can be
used effectively to promote functional recovery. For instance, it is
not clear whether these neuroblasts have the potential to differ-
entiate into cortical neurons, or whether NSCs and neuroblasts can
generate enough neurons to promote functional recovery. Since
self-recovery is not sufﬁcient for functional brain regeneration, the
effective use of endogenous NSCs to regenerate the cerebral cortex
will require a breakthrough technique, such as a method for
expanding NSCs and neuroblasts in vivo.
2.3. Cell cycle
Neurons are believed to be post-mitotic and non-dividing
because of a fundamental principle in developmental biology:
cell differentiation and proliferation are mutually exclusive [31]. In
general, when differentiated cells proliferate, they de-differentiate
before advancing their cell cycle. Cell differentiation and prolifer-
ation are tightly coupled in neurons. Although neurons can
advance their cell cycle in pathological situations such as ischemia
and Alzheimer's disease, they undergo cell death after re-entering
the cell cycle [32]. Techniques to uncouple proliferation from
neuronal differentiation might contribute to alternative cortical
regeneration therapies, and recent ﬁndings in cell-cycle mechanics
and neurobiology suggest new strategies for developing such
techniques.
One cell becomes two cells after cell-cycle events such as DNA
replication in the S phase and cell division in the M phase. The G1
and the G2 phases are gap phases that prepare the cell to advance
into the S and the M phases, respectively. During the G1 phase,
retinoblastoma protein (Rb) and its family members (p107 and
Fig. 1. Neurobiological and biomaterial-engineering approaches for regenerating
the injured cerebral cortex Injured neurons are replaced by 1) neural cell trans-
plantation, 2) endogenous neuroblast migration and proliferation, and/or 3)
endogenous neuron proliferation. Transplanted biomaterials, either with or
without living cells, can accelerate cortical regeneration..
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phase [33,34]. During G1 to S phase progression, cyclin D and
cyclin-dependent kinase (Cdk) 4/6 complex phosphorylates Rb
family members, which induce the dissociation of the Rb family
from E2F transcriptional factors and the S phase-related gene to
express. The loss of Rb in post-mitotic neurons induces cell-cycle
reentry and causes cell death, probably because of the tight
coupling of proliferation and neuronal differentiation [35].
Rb-family members also control the tight coupling of neuronal
differentiation and proliferation in progenitor but not post-mitotic
cells. In addition to directly regulating the transcription of cell-
cycle-related genes, the Rb family regulates epigenetic modiﬁca-
tions by associating with various epigenetic modiﬁers [31,33]. In
human retinoblastoma, RB1-mediated epigenetic regulation con-
tributes to cancer progression [36]. During cancer progression,
retinoblastoma cells co-express genes that are normally expressed
in only one retinal-cell type [37]; thus, the loss of the Rb family in
retinal progenitors can uncouple proliferation from neuronal dif-
ferentiation by epigenetic dysregulation. Indeed, when neurons
lose the tight coordination between cell-cycle exit and neuronal
differentiation by the loss of the Rb family in progenitor cells,
neurons can divide in some cases. For example, retinal progenitor
cells lacking Rb-family members other than one p107 allele fully
differentiate into horizontal interneurons [38]. However, p107-
single (Rb/; p107þ/; p130/) differentiated horizontal in-
terneurons proliferate without de-differentiation and form tumors.
In the mouse cerebral cortex, the loss of the Rb family or just Rb in
progenitors causes immature neurons to divide [39e41]. However,
the loss of the Rb family in post-mitotic neurons immediately after
exiting the cell cycle does not cause cell division, even though the
cells undergo S-phase progression [39]. Thus, once progenitor
daughter cells exit their cell-cycle and initiate neuronal differenti-
ation, they become tightly protected from undergoing cell division,
and thereby maintain mitotic resistance even after acute Rb family
inactivation. These ﬁndings lead us to speculate that neurons in the
S phasemay escape cell death and divide by overriding suchmitotic
safeguards. Importantly, in pathological situations, postmitotic
neurons can advance their cell cycle, but then undergo cell death
instead of cell division. For example, in pathological situations such
as Alzheimer's disease (AD), Parkinson's disease (PD), and mouse
stroke model, neurons advance their cell-cycle into the S phase and
then undergo cell death [42e45]. Since the inhibition of cell-cycle
reentry by Cdk inhibitor prevents pathological neuron death [46],
cell-cycle reentry contributes to disease progression. Moreover, Rb
phosphorylation is correlated with the cell-cycle reentry of path-
ological neurons [47,48] and the progression of AD [49,50]. Thus,
the safeguard against cell division may prevent neurons from
entering theM phase but instead to lead cell death subsequent to S-
phase progression. Since pathological neurons undergo cell death
after re-entering the cell cycle, the transient inactivation of such
mitotic safeguards and later the inactivation of Cdk to prevent
multiple cell cycle reentry is an attractive regenerative strategy to
replace dying neurons with new neurons.
3. Biomaterial-engineering approaches to cortical
regeneration
3.1. Biomaterials without cell transplantation
Although recent neurobiological studies show that the injured
CNS has the potential to regenerate, self-recovery is not sufﬁcient
for functional regeneration and recovery. Thus, biomaterials engi-
neered to accelerate regeneration are an important strategy for
functional recovery. Potential regenerative strategies using
endogenous NSCs face a technical obstacle: the migratingneuroblasts cannot align in the cortical lesion because they do not
pass through the glial-scar barrier formed by reactive astrocytes in
response to brain injury. Since migrating neuroblasts generated
from endogenous NSCs use blood vessels as a scaffold to move
toward a brain lesion [51e53], blood-vessel-like biomaterials can
be used as a scaffold to allow migrating neuroblasts to pass
through the glial-scar barrier. We recently developed a laminin-
rich sponge material for the three-dimensional (3D) proliferation
culture of p107-single horizontal interneurons [54]. Since laminin
is a primary component of the extracellular matrix in the basement
membrane on the surface of blood vessels, we transplanted the
laminin-rich sponge material into the injured cerebral cortex [55].
As expected, neuroblasts migrated into the cortical lesion along the
laminin-rich sponge material. Thus, blood-vessel-like biomaterials
can support neuroblast migration, which is important for cortical
regeneration. Other transplanted biomaterials are reported to
enhance the regenerative process [56e58]. Furthermore, engi-
neered biomaterials that release a bioactive factor to promote the
formation of new blood vessels may promote neuronal migration
and survival, and biomaterials that release a bioactive factor to
enhance neuronal maturation may enhance neuronal connections
to other areas of the brain.3.2. Biomaterials with cell transplantation
Biomaterials were originally deﬁned as nonviable materials
designed to interact with biological systems when used in medical
devices [59]. However, biomaterials now include transplantable
hybrids containing both nonviable materials and living cells [60]. A
combination of neural stem/progenitor cell transplantation and
biomaterials can enhance the regenerative process and promote
functional cortical recovery in some cases [61e64]. Again, to
develop reliable regenerative therapies for functional recovery, we
must determine which factors are essential during the regenera-
tive process.4. Future perspectives
In the past few years, remarkable advances have been made in
culturing 3D organoids from pluripotent stem cellsdretinal
I. Ajioka / Regenerative Therapy 3 (2016) 63e6766organoids, for example [65]. This technology has great potential
not only for determining the potency of pluripotent stem cells to
generate self-organizing neural tissue, but also for retinal regen-
eration therapy. Transplants of 3D retinal organoids derived from
pluripotent stem cells promote retinal regeneration in mice, even
when advanced degeneration is present [66]. Cerebral organoids
have also been generated from pluripotent stem cells [67,68], and
the potential use of these organoids for regenerating the injured
cerebral cortex merits further study.
Recent advances in neurobiology and in biomaterial engineer-
ing shed new light on the potential of cortical regeneration, and
researchers have tried various methods to promote regeneration
(see Fig. 1). Although functional recovery has occurred after neural
stem/progenitor cell transplantation, careful analysis is required to
understand how neuronal networks regenerate. There is no doubt
that the cerebral cortex has the potential to regenerate after injury.
Future studies combining neurobiology and biomaterial engi-
neering will drive the development of therapeutic strategies to
regenerate the injured cerebral cortex.Acknowledgments
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